Tincture Takeaways

Tincture may be (mostly) on a hiatus, but the coronavirus pandemic calls for special attention. We highlight any COVID-19 perspectives that Tincture published last week, as well as other non-Tincture COVID-19 articles that founder Jordan Shlain and editor Kim Bellard thought you should see.

Tincture Takeaways

It’s going to be a long winter. Jordan Shlain, M.D. Dispatch #14 — Politics + Science ≠ Political Science

Jordan’s Takeaways

Biotech is not tech. Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients

“Low tech” matters. Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions

Kim’s Takeaways

Why’s that?? Internal Documents Reveal COVID-19 Hospitalization Data The Government Keeps Hidden

We keep finding things out. Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020

Some good news… Death Rates Have Dropped for Seriously Ill Covid Patients

…and some worse news. First, coronavirus infections increased. Then, hospitalizations. Now, deaths are on the rise.

About that “warp speed.” It may be time to reset expectations on when we’ll get a Covid-19 vaccine

Let’s hope. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months